The Patent Finder

Hutchison Medipharma Limited

28 patents currently held · Updated Nov 17, 2026
6 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

Recorded as renamed to Hutchmed Limited (2022)

6
Ending by 2030
Nov 2030
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Nov 23, 2026
    The maintenance fee for Substituted Piperazines as BTK Inhibitors (US 11,655,254) comes due Nov 23, 2026. Unpaid by May 24, 2027, it lapses early.
  • 1 fee due Jun 24, 2027
    The maintenance fee for Certain Triazolopyridines and Triazolopyrazines, Compositions Thereof and Methods of Use Therefor (US 10,512,645) comes due Jun 24, 2027. Unpaid by Dec 27, 2027, it lapses early.
  • 1 fee due Aug 13, 2027
    The maintenance fee for Certain Triazolopyridines and Triazolopyrazines, Compositions Thereof and Methods of Use Therefor (US 11,896,592) comes due Aug 13, 2027. Unpaid by Feb 14, 2028, it lapses early.
  • 1 fee due Oct 7, 2027
    The maintenance fee for Novel Imidazopyridazine Compounds and Their Use (US 10,611,777) comes due Oct 7, 2027. Unpaid by Apr 7, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 of the patents on this record was granted since Aug 19, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 8,946,249Compound, Certain Novel Forms Thereof, Pharmaceutical Compositions Thereof and Methods for Preparation and Use
In force
 · Low confidence
In forceLow confidence
US 8,507,487Certain Triazolopyridines and Triazolopyrazines, Compositions Thereof and Methods of Use Therefor
In force
 · High confidence
In forceHigh confidence
US 8,987,269Certain Triazolopyridines and Triazolopyrazines, Compositions Thereof and Methods of Use Therefor
In force
 · High confidence
In forceHigh confidence
US 9,956,218Certain Triazolopyridines and Triazolopyrazines, Compositions Thereof and Methods of Use Therefor
In force
 · High confidence
In forceHigh confidence
US 10,512,645Certain Triazolopyridines and Triazolopyrazines, Compositions Thereof and Methods of Use Therefor
In force
 · High confidence
In forceHigh confidence
US 10,946,014Certain Triazolopyridines and Triazolopyrazines, Compositions Thereof and Methods of Use Therefor
In force
 · High confidence
In forceHigh confidence
US 11,896,592Certain Triazolopyridines and Triazolopyrazines, Compositions Thereof and Methods of Use Therefor
In force
 · High confidence
In forceHigh confidence
US 10,052,330Substituted pyrido[3,4-b]pyrazines as Syk inhibitors
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,434,726Substituted pyrido[3,4-b]pyrazines as Syk inhibitors
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,701,680Pyrimidine and pyridine compounds and their usage
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 28 patents shown.
Pro members see all 28.
Pro members: see all 28 patents
Also on record, not counted in the 28: 6 patents in force now held by others · 7 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

8 pending · 2 abandoned · 8 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited